每經(jing)AI快(kuai)訊，佐(zuo)力藥業（SZ 300181，收盤價(jia)：16.15元）10月27日(ri)晚間發布公(gong)告稱，本激(ji)勵(li)計(ji)劃擬(ni)首次(ci)授予(yu)的激(ji)勵(li)對(dui)象(xiang)總人數為(wei)112人，股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)來源為(wei)公(gong)司從二(er)級市場回(hui)購(gou)的公(gong)司A股(gu)(gu)(gu)(gu)(gu)(gu)(gu)普通(tong)(tong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)；擬(ni)向激(ji)勵(li)對(dui)象(xiang)授予(yu)限(xian)制性(xing)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)不(bu)超過約660萬股(gu)(gu)(gu)(gu)(gu)(gu)(gu)，涉及的標的股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)種類為(wei)人民幣A股(gu)(gu)(gu)(gu)(gu)(gu)(gu)普通(tong)(tong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)，約占(zhan)本激(ji)勵(li)計(ji)劃公(gong)告日(ri)公(gong)司總股(gu)(gu)(gu)(gu)(gu)(gu)(gu)本約7.01億股(gu)(gu)(gu)(gu)(gu)(gu)(gu)的0.94%；首次(ci)授予(yu)限(xian)制性(xing)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)的價(jia)格為(wei)8.07元/股(gu)(gu)(gu)(gu)(gu)(gu)(gu)，即滿足授予(yu)條(tiao)件和歸屬條(tiao)件后，激(ji)勵(li)對(dui)象(xiang)可以每股(gu)(gu)(gu)(gu)(gu)(gu)(gu)8.07元的價(jia)格購(gou)買公(gong)司從二(er)級市場回(hui)購(gou)的本公(gong)司A股(gu)(gu)(gu)(gu)(gu)(gu)(gu)普通(tong)(tong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)，有效(xiao)期(qi)自限(xian)制性(xing)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)首次(ci)授予(yu)之日(ri)起至激(ji)勵(li)對(dui)象(xiang)獲授的限(xian)制性(xing)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)票(piao)(piao)全(quan)部歸屬或作廢失效(xiao)之日(ri)止，最長不(bu)超過60個月。

截至(zhi)發稿，佐力(li)藥業(ye)市值(zhi)為113億(yi)元。

道達號（daoda1997）“個股趨勢(shi)”提醒：
1. 近30日內無機構對佐力藥業進行調研。

每經頭條（nbdtoutiao）——

(記者 蔡鼎)

免責聲(sheng)明：本文內(nei)容(rong)與數(shu)據(ju)僅(jin)供(gong)參(can)考，不構成(cheng)投資建議，使用前請(qing)核實。據(ju)此操(cao)作，風險自擔。